GMP Insiders - Your trusted source for GMP compliance!

6 Steps on How to Perform Root Cause Analysis (RCA)

Related topics

6 Steps on How to Perform Root Cause Analysis (RCA)

Root Cause Analysis (RCA) is a systematic approach used to identify the fundamental causes of problems or deviations in pharmaceutical manufacturing. Within the framework of Good Manufacturing Practice (GMP), RCA is critical for maintaining product quality and ensuring patient safety. Effective RCA prevents the recurrence of issues by targeting the underlying causes rather than merely addressing symptoms.

This article will explain RCA in detail, outline the common triggers that necessitate RCA in the pharmaceutical industry, and provide a step-by-step approach to performing a robust RCA. 

What Is Root Cause Analysis?

Root Cause Analysis is a problem-solving technique that pinpoints the exact cause(s) of a problem. Unlike superficial investigations that focus on immediately obvious symptoms, RCA delves deeper to uncover the true origins of an issue. 

RCA involves systematically exploring all possible causes of a problem, analyzing evidence, and using structured methodologies to establish the primary factor(s) responsible for an undesirable event. Effective RCA ensures that corrective and preventive actions are appropriately designed to minimize or eliminate the risk of recurrence.

Key Elements of RCA in the Pharmaceutical Industry

Some of the key elements of root cause analysis include:

  • Systematic Investigation: RCA is a carefully planned and structured process, not an ad hoc or inconsistent effort. It requires collecting and analyzing data using tools and methodologies like the 5 Whys, Ishikawa diagrams, or Failure Modes and Effects Analysis (FMEA).
  • Evidence-Based Analysis: Objective evidence is crucial for RCA’s credibility. This involves examining production records, equipment logs, and environmental monitoring data, as well as interviewing staff involved in the incident.
  • Focus on Prevention: RCA’s primary goal is to identify and rectify the root cause, ensuring that similar issues do not arise in the future. This focus on prevention supports the continuous improvement of manufacturing processes and quality systems.

Common Triggers for Conducting RCA in GMP

RCA Triggers in GMP

RCA is typically triggered by significant events that could impact product quality, patient safety, or regulatory compliance. Below are the common scenarios that necessitate an RCA:

Deviations

Deviations are departures from established procedures, specifications, or accepted standards.

Deviation Example: A deviation occurs if a product batch does not meet the temperature requirements during a sterilization process.

Deviation Impact: Deviations must be investigated thoroughly to understand the cause and ensure they do not compromise product quality or patient safety.

Product Recalls and Quality Complaints

Product Recalls: A recall is initiated when a product is found to be defective or potentially harmful. RCA is performed to trace the issue back to its origin, whether it involves raw materials, manufacturing processes, or packaging.

Quality Complaints: Complaints from healthcare professionals or patients, such as unexpected adverse effects or packaging defects, also trigger RCA.

Example: A recall caused by contamination may lead to an RCA that uncovers an inadequate cleaning procedure in a manufacturing area.

Inspection Findings and Audit Observations

Regulatory agencies like the FDA or EMA and internal quality audits may uncover GMP non-compliance or quality management system weaknesses.

Example: An audit observation citing poor documentation practices would prompt RCA to determine the root cause, such as insufficient staff training or unclear standard operating procedures (SOPs).

RELATED ARTICLE: Tips on How to Prepare for a GMP Inspection

Human Errors

Mistakes made by personnel are a common occurrence in manufacturing. However, human errors are often symptoms of deeper systemic issues, such as inadequate training, poorly designed work environments, or complex procedures.

Example: An operator failing to follow a critical step in a process may be traced to ambiguous instructions or excessive workload.

Equipment Failures 

Equipment failures refer to malfunctions, breakdowns, or performance deviations in manufacturing, testing, and monitoring equipment. 

Example: A pharmaceutical company performing sterile injectables manufacturing experiences a sterility failure during routine microbiological testing. RCA is triggered to determine whether equipment failure is a contributing factor.

Key Steps to Perform Root Cause Analysis

Root Cause Analysis Flowchart

A successful RCA requires a systematic and methodical approach to ensure the identification of the actual root cause and the implementation of effective corrective and preventive actions. Here’s a breakdown of the key steps involved:

Step 1: Problem Identification

Objective: Clearly and comprehensively define the problem at hand.

Approach: Develop a precise problem statement that captures the essential details of the issue. This step ensures a shared understanding of what needs to be addressed and sets the foundation for the investigation.

  • What: Describe the nature of the problem in specific terms.
  • When and Where: Identify the time and location of the incident to understand its context.
  • Who: Specify any personnel, departments, or systems affected.
  • Impact: Detail how the issue affects product quality, patient safety, regulatory compliance, or operational efficiency.

Example:

Problem Statement: “On March 5th, Batch #12345 produced in Filling Line 3 failed bioburden testing, indicating microbial contamination that compromises product sterility and patient safety.”

  • What: A batch of sterile product failed bioburden testing.
  • When and Where: The issue was discovered on March 5th during routine quality control testing of Batch #12345, produced in Filling Line 3.
  • Who: The issue affects the quality control (QC) lab, sterile manufacturing team, and patient safety.
  • Impact: The contamination poses a serious risk to product sterility, which could lead to product recall, regulatory action, and harm to patients.

Step 2: Data Collection and Analysis

Objective: Gather all relevant information to gain a comprehensive understanding of the problem.

Types of Data

  • Process Data: Collect equipment logs, process control charts, environmental monitoring records, and batch documentation to identify process variability or inconsistencies.
  • Personnel Data: Review training records, shift schedules, and conduct interviews with staff involved to determine if human factors contributed to the issue.
  • Historical Data: Examine past deviations, non-conformities, and related incident reports to see if similar problems have occurred and what actions were taken.

Analysis Techniques: Apply statistical tools, trend analysis, or process mapping to uncover patterns, correlations, or anomalies.

Example

  • Process Data: Review batch records, equipment logs, cleanroom environmental monitoring data, and details of the aseptic process used during the batch production.
  • Personnel Data: Collect operators’ training records, check adherence to gowning procedures, and interview the team members involved in the manufacturing process.
  • Historical Data: Examine past deviations or contamination events on Filling Line 3 to identify any recurring trends.

Environmental monitoring data reveal that the microbial counts in the cleanroom were slightly elevated two days before Batch #12345 was processed. Equipment maintenance logs show that one of the sterilization autoclaves had an unplanned maintenance event before production.

Step 3: Identifying Potential Causes

Objective: Brainstorm all possible causes of the issue in collaboration with a multidisciplinary team.

Tools: To systematically capture and organize potential causes, use structured brainstorming sessions, process flowcharts, or affinity diagrams.

Team Composition: Assemble a team that includes representatives from quality assurance, manufacturing, engineering, validation, and relevant subject matter experts. A diverse group ensures a comprehensive perspective on the issue.

Example

Objective: Brainstorm all possible causes of the bioburden contamination.

Team Composition: Include members from Quality Assurance (QA), Quality Control (QC), Manufacturing, Engineering, Microbiology, and Validation.

SEE ALSO: QA vs QC

Tools Used:

  • Brainstorming session to list potential causes.
  • Ishikawa (Fishbone) Diagram to categorize causes under headings such as Equipment, Personnel, Methods, Materials, and Environment.

Potential Causes Identified:

  • Equipment: Sterilization autoclave malfunction.
  • Personnel: Improper gowning or aseptic technique by operators.
  • Methods: Inadequate cleaning and disinfection of the cleanroom.
  • Materials: Contaminated raw materials or components.
  • Environment: High microbial counts in the cleanroom air.

The team identifies that multiple factors could have contributed, such as equipment issues with the autoclave, deviations in gowning practices, or a lapse in the cleanroom sanitation protocol.

Step 4: Determining the Root Cause

Objective: Use systematic techniques to narrow down the actual root cause(s) from the list of potential causes.

RCA Tools and Methods

5 Why’s Technique: Ask “Why?” repeatedly (typically five times) to drill down to the root cause. Each answer forms the basis of the next question.

Ishikawa (Fishbone) Diagram: Categorize causes under major headings like Methods, Materials, Machines, Manpower, Measurement, and Environment, providing a comprehensive visual analysis of potential root causes.

Failure Modes and Effects Analysis (FMEA): Evaluate potential failure points and assess the impact and likelihood of each to prioritize high-risk areas.

Example

How to Structure 5 Why's Analysis

  • 5 Why’s Technique: To drill down into the equipment issue.
    • Why did the batch fail bioburden testing? → Because of microbial contamination.
    • Why was there microbial contamination? → The sterility assurance process failed.
    • Why did the sterility assurance process fail? → The sterilization autoclave used for sanitizing equipment had performance issues.
    • Why did the autoclave have performance issues? → It had a history of temperature fluctuations during cycles.
    • Why were these temperature fluctuations not addressed? → Preventive maintenance was overdue, and monitoring systems failed to detect temperature deviations promptly.

Root Cause Identified: The sterilization autoclave had a performance issue due to overdue preventive maintenance, resulting in inadequate sterilization.

Step 5: Implementing Corrective and Preventive Actions (CAPA)

Objective: Develop and implement CAPAs that address the root cause and prevent future occurrences.

Corrective Actions: Immediate steps to rectify the problem and minimize its impact.

Preventive Actions: Systemic measures to prevent recurrence by strengthening processes or systems.

CAPA Planning: Use the SMART criteria to ensure CAPAs are:

  • (S)pecific: Clearly define the action to be taken.
  • (M)easurable: Include criteria to evaluate success.
  • (A)chievable: Ensure the plan is realistic and feasible.
  • (R)elevant: Address the identified root cause.
  • (T)ime-bound: Specify deadlines for implementation and review.

Documentation: Maintain comprehensive records of all CAPA activities, including implementation timelines, responsibilities, and verification results.

RELATED ARTICLE: CAPA Plan in GMP

Example:

Objective: Design and implement CAPAs to eliminate the root cause and prevent recurrence.

Corrective Actions:

  • Repair and recalibrate the sterilization autoclave immediately.
  • Reprocess or discard Batch #12345 to ensure no contaminated product is released.
  • Conduct a comprehensive retraining session for staff on the importance of reporting and addressing equipment alarms.

Preventive Actions:

  • Update the preventive maintenance schedule to include more frequent checks and calibrations for all critical equipment.
  • Implement automated monitoring systems to alert staff in real-time if equipment performance deviates from specifications.
  • Conduct periodic audits of the maintenance program and cross-train staff to ensure backup coverage for maintenance tasks.

Step 6: Monitoring and Effectiveness Checks

Objective: Verify that the CAPAs are effective and sustainable over the long term.

Approach:

  • Effectiveness Checks: Conduct follow-up audits and review key performance indicators (KPIs) to ensure the implemented actions have resolved the issue. This may include testing the new procedures or inspecting equipment performance.
    • Example: Conduct a follow-up audit to ensure the sterilization autoclave operates correctly and the maintenance logs are current.
  • Continuous Monitoring: Use statistical process control and ongoing data analysis to detect any early warning signs of potential issues.
    • Example: Review environmental monitoring data and equipment performance metrics for several subsequent production batches.
  • Documentation: Keep detailed records of monitoring activities, including effectiveness check results, trends, and any observations that could inform future improvements.
    • Example: Track the percentage of maintenance tasks completed on time and monitor the bioburden testing results for subsequent batches.

After implementing the new maintenance schedule, review the sterilization autoclave’s performance data over the next three months. Confirm that temperature deviations no longer occur and that bioburden test results remain within acceptable limits.

Linking RCA to CAPA and Continuous Quality Improvement

RCA is not a standalone process but is deeply integrated into the CAPA system and overall quality management. The insights gained from RCA inform the design and implementation of effective CAPAs, which are essential for maintaining GMP compliance and product quality.

CAPA and Continuous Quality Improvement (CQI)

  • Preventive Approach: RCA outcomes contribute to CQI by highlighting process enhancement and risk reduction areas.
  • Regulatory Compliance: Regulatory bodies expect pharmaceutical companies to use RCA effectively to address issues and document the process comprehensively.
  • Quality Culture: Emphasizing RCA and CAPA fosters a culture of quality, accountability, and continuous improvement across the organization.

Key Considerations

  • Ensure all RCA activities are well-documented to satisfy regulatory scrutiny.
  • Train personnel in RCA methodologies to improve investigation effectiveness.
  • Use RCA findings to refine quality systems, such as updating SOPs, improving training programs, or investing in better technology.

FAQ

How Do We Ensure RCA Is Unbiased?

Form a multidisciplinary investigation team to minimize individual biases. Use objective data and evidence-based methods for analysis.

What if the Root Cause Is Unclear Even After RCA?

If the root cause remains elusive, reassess data collection quality, use additional RCA tools, or seek external expert input. Sometimes, complex issues may have multiple root causes.

Can RCA Be Performed for Proactive Risk Management?

Yes, RCA is effective for proactive risk assessments, such as evaluating process changes or new equipment to prevent issues before they occur.

How Long Should an RCA Take?

The duration of an RCA depends on the complexity of the issue. For minor problems, RCA may be completed in a few days, but complex investigations can take weeks. The priority is thoroughness over speed.

Conclusion

By systematically identifying and addressing the underlying causes of problems rather than merely treating their symptoms, RCA prevents issues from recurring and strengthens overall process reliability. RCA lays the foundation for continuous improvement in quality systems through a structured approach, including problem identification, data collection, analysis, and implementation of corrective and preventive actions.

RCA is more than a reactive problem-solving tool – it is a proactive strategy embedded in the culture of quality assurance and continuous improvement. By using RCA insights to refine processes, enhance training, and optimize systems, pharmaceutical companies can uphold high safety and efficacy standards while meeting stringent regulatory expectations.

Subscribe to our Newsletter

Sign up to recieve latest news, GMP trends and insights from our industry experts

Latest GMP Posts

BECOME A GMP INSIDER

Stay in touch and be the first to get the latest GMP News